FdaApplication
NDA 209501
Identifiers
- fda_app_no: NDA209501
Properties
| Property | Value |
|---|---|
| applicant_name | UPJOHN US 2 LLC |
| application_type | NDA |
| approval_date | 2017-10-11 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LYRICA CR | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE;ORAL |
| LYRICA CR | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE;ORAL |
| LYRICA CR | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE;ORAL |
3 products